How to Reconstitute Peptides: Bacteriostatic Water, Step by Step

Research peptides almost never arrive ready to use. They ship as a small amount of white, freeze-dried (lyophilized) powder sitting in the bottom of a sealed glass vial, and before that powder can be drawn into a syringe it has to be dissolved in liquid — a step the community calls "reconstitution." This article explains how that is done and, just as importantly, how the simple-sounding concentration math actually works, so you understand what a number like "250 mcg" means once the powder is in solution.

Before any of that, the framing that matters most: the peptides people reconstitute this way — BPC-157, TB-500, the GH-axis peptides — are not FDA-approved medicines. They are sold "for research use only," they are banned in tested sport, and nothing below is a recommendation to inject anything. We cover the legality and the gray-market sourcing problem in depth in our guide to whether GH peptides are safe and legal, and the unanswered human-dosing question in our look at BPC-157 dosage. This is a mechanical explainer, not a protocol.

What "reconstitution" actually is

Lyophilization — freeze-drying — is how peptides are stabilized for shipping and storage, because most peptides are far more stable as a dry solid than dissolved in water. Once a peptide is back in aqueous solution, it becomes vulnerable to slow chemical breakdown: hydrolysis, deamidation, and oxidation that nibble at the molecule over days to weeks, with the rate depending heavily on pH, temperature, and time in solution¹. That single fact drives almost every practical reconstitution rule you will read: keep the reconstituted vial cold, use it within a reasonable window, and don't mix more than you'll use, because the clock starts the moment the powder dissolves.

The water: bacteriostatic vs. sterile vs. everything else

The liquid you add is not water from the tap, and the choice is not cosmetic.

Bacteriostatic water is sterile water that contains a small amount of benzyl alcohol (typically 0.9%) as a preservative. The benzyl alcohol suppresses bacterial growth, which is what makes a multi-use vial — one you'll puncture repeatedly over days or weeks — relatively safer than plain water, where any introduced microbe could multiply. That is the practical reason it is the default mixing fluid for multi-dose peptide vials.

Sterile water for injection has no preservative. It is intended for single use, because once a microbe is introduced there is nothing to hold it back.

The benzyl alcohol in bacteriostatic water is also why it is not a universally "safe" choice for everyone: benzyl alcohol is not an inert ingredient. In neonates it has caused a fatal "gasping syndrome" from benzyl-alcohol poisoning when used as a preservative in flush solutions² — which is precisely why preserved bacteriostatic products carry warnings against use in newborns and why this whole topic sits firmly in adult, research-only territory. (None of this makes any peptide approved for human use; it is context for why the choice of diluent is a real pharmacology question, not a detail.)

The concentration math (the part people get wrong)

Here is the step most newcomers find confusing, and it is pure arithmetic. The peptide's effect depends on the mass you draw — measured in micrograms (mcg) or milligrams (mg) — but a syringe measures volume in units or milliliters. Reconstitution is the bridge between the two.

The vial is labeled by mass: a "5 mg" vial contains 5 mg (5000 mcg) of peptide as powder. The concentration after mixing is simply:

concentration = total peptide mass ÷ volume of water added.

Add 2 mL of bacteriostatic water to a 5 mg vial and you get 5000 mcg ÷ 2 mL = 2500 mcg per mL. On a standard U-100 insulin syringe (100 "units" = 1 mL), that means each unit holds 25 mcg. Add 1 mL instead and the same vial becomes 5000 mcg/mL, or 50 mcg per unit — same powder, double the concentration, half the volume per dose. The powder didn't change; only the dilution did.

This is why "how much water do I add?" has no single right answer — it sets the concentration, and people pick a volume that makes their intended dose land on an easy-to-measure number of syringe units. The arithmetic is trivial; the part that is not trivial is that the dose those units correspond to is, for these peptides, not validated in humans in the first place. An exact volume calculation gives a false sense of precision to a quantity nobody has established as safe or effective.

The mechanical steps (and where the real risk is)

The physical procedure is undramatic. The vial of powder and the bacteriostatic water both have rubber stoppers; the stoppers are wiped with an alcohol swab; water is drawn into a syringe and added to the powder vial slowly, ideally letting it run down the inside glass wall rather than blasting directly onto the powder, because peptides are fragile and harsh agitation can degrade them. The vial is then swirled gently — not shaken — until the powder fully dissolves into a clear solution. A solution that stays cloudy, or shows visible particles after it should have dissolved, is a reason to stop, not to inject.

The genuine hazards here are not the math. They are sterility and the product itself. Every puncture is an opportunity to introduce bacteria; aseptic technique (clean hands, swabbed stoppers, never touching the needle) is the standard borrowed from insulin and other subcutaneous self-injection practice³. And because these are unregulated research chemicals, the vial's contents are an unknown — third-party testing routinely finds sports and "research" products that are underdosed, overdosed, mislabeled, or contaminated with substances never on the label⁴. No reconstitution technique fixes a vial that contained the wrong thing to begin with. For the route-and-technique side of what happens after mixing, see subcutaneous vs. intramuscular injection.

Storage after mixing

Once reconstituted, the peptide is in its least stable state. The shared community practice — keep the vial refrigerated, protect it from light, and use it within roughly a few weeks — is downstream of the chemistry above: dissolved peptides degrade faster at room temperature and over time¹. This is also consistent with how short-lived these molecules are biologically; BPC-157's own development literature notes a plasma half-life under 30 minutes and a still-rudimentary pharmaceutical profile with no validated formulation⁵, which is a useful reminder that even a perfectly mixed vial is not a finished, characterized drug.

The bottom line

Reconstituting a peptide is genuinely simple chemistry: dissolve a known mass of powder in a known volume of preserved water, and the concentration falls out of one division. Bacteriostatic water is the usual diluent because its benzyl alcohol lets a vial survive repeated punctures, while plain sterile water is single-use — and benzyl alcohol's own toxicity history is a reminder that even the "inactive" ingredient isn't inert². But none of this technique changes the larger reality: these are unapproved, sport-banned research chemicals of uncertain content, with no validated human dose, and the cleanest mixing technique in the world cannot make an unproven substance proven. For where this fits in the broader recovery-peptide picture, start with our pillar on peptides for recovery and healing, and for how the actual products and providers compare, see our best recovery peptides hub. If you stack multiple peptides, the mixing logic compounds — we walk through that in the ipamorelin + CJC-1295 stack and the BPC-157 + TB-500 stack.